| dc.contributor.author | Mather, Ian | |
| dc.contributor.author | Dawoud, Dalia M | |
| dc.contributor.author | Donald, Ian | |
| dc.contributor.author | Chandra, Deepak | |
| dc.contributor.author | Sharpin, Carlos | |
| dc.contributor.author | Stansby, Gerard | |
| dc.contributor.author | Barry, Peter | |
| dc.date.accessioned | 2020-05-22T00:02:46Z | |
| dc.date.available | 2020-05-22T00:02:46Z | |
| dc.date.issued | 2018-11-10 | |
| dc.identifier.citation | Mather , I , Dawoud , D M , Donald , I , Chandra , D , Sharpin , C , Stansby , G & Barry , P 2018 , ' Cost Impact Analysis of Using The Improve® Tool For Venous Thromboembolism Risk Assessment In Medical Patients Admitted to The UK NHS Hospitals to Inform NICE Clinical Guideline Recommendation ' , ISPOR Europe 2018 , Barcelona , Spain , 10/11/18 - 14/11/18 . | |
| dc.identifier.citation | conference | |
| dc.identifier.other | ORCID: /0000-0002-2105-1937/work/74458399 | |
| dc.identifier.uri | http://hdl.handle.net/2299/22739 | |
| dc.description | © 2018 The Author(s). This an open access work distributed under the terms of the Creative Commons Attribution Licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. | |
| dc.format.extent | 9590 | |
| dc.language.iso | eng | |
| dc.title | Cost Impact Analysis of Using The Improve® Tool For Venous Thromboembolism Risk Assessment In Medical Patients Admitted to The UK NHS Hospitals to Inform NICE Clinical Guideline Recommendation | en |
| dc.contributor.institution | School of Life and Medical Sciences | |
| dc.contributor.institution | Department of Pharmacy, Pharmacology and Postgraduate Medicine | |
| dc.contributor.institution | Department of Clinical and Pharmaceutical Sciences | |
| dc.description.status | Peer reviewed | |
| rioxxterms.type | Other | |
